ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Paul Rambaut Leaving NCI For NATO Position; Niederhuber New Cancer Commission Chairman

December 9, 1988

The FY 1984 Bypass Budget: How NCI Would Spend the Money

July 9, 1982

NCI Awards $10 Million To States for Cervix Screening

September 27, 1974

Consortium Centers Pose Problems To Some, But claim They “Coincide With Congress’ Intent”

December 9, 1977

New Cooperative Group Funded

September 30, 1977

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996